Cargando…
An Introduction to Managing Medullary Thyroid Cancer
MTC is a rare neuroendocrine thyroid tumour accounting for 3% to 10% of all thyroid malignancies. It can occur in a sporadic and a hereditary clinical setting. Hereditary MTC may either occur alone (familial MTC, FMTC) or as part of multiple endocrine neoplasia (MEN) type 2A, or MEN 2B. These disord...
Autores principales: | de Groot, Jan Willem, Links, Thera P, Hofstra, Robert MW, Plukker, John TM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177236/ https://www.ncbi.nlm.nih.gov/pubmed/20223015 http://dx.doi.org/10.1186/1897-4287-4-3-115 |
Ejemplares similares
-
Surgical Complications and Referral Patterns in 567 Patients with Differentiated Thyroid Cancer in the Northern Region of the Netherlands: A Population-Based Study Towards Clinical Management Implementation
por: van Dijk, Deborah, et al.
Publicado: (2020) -
Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer
por: Groen, Andries H, et al.
Publicado: (2021) -
Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”
por: Jarzab, Barbara, et al.
Publicado: (2013) -
A Sensitive Tg Assay or rhTSH Stimulated Tg: What's the Best in the Long-Term Follow-Up of Patients with Differentiated Thyroid Carcinoma?
por: Persoon, Adrienne C.M., et al.
Publicado: (2007) -
Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)